How to Get Synagis (Palivizumab) Covered by Humana in New Jersey: Complete PA Guide and Appeals Process
Quick Answer: Synagis (palivizumab) requires prior authorization from Humana in New Jersey. High-risk infants under 12 months with specific conditions (prematurity ≤35 weeks, chronic lung disease, congenital heart disease) are eligible. Submit Humana's Antiviral Monoclonal Antibodies PA form with clinical documentation. If denied, you have 65 days to